Royan Institute
Iran
- Country
- Iran
- Ownership
- Private
- Established
- 1991-01-01
- Employees
- -
- Market Cap
- -
The Effect of Combination of Red and White Bahman Retrieved of Iranian Traditional Medicine on Semen Parameters in Idiopathic Oligospermic Men
Phase 3
- Conditions
- Infertility, Male
- Interventions
- Drug: Bahman capsulesDrug: Placebo
- First Posted Date
- 2016-12-20
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 200
- Registration Number
- NCT02998593
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Embryo Transfer on Pregnancy Outcomes in Frozen Embryo Transfer Cycles.
Phase 3
Completed
- Conditions
- Infertility
- Interventions
- Drug: Intra uterine injection of tissue culture medium containing HCG+ETDrug: Intra uterine injection of tissue culture medium +ETProcedure: ET
- First Posted Date
- 2016-07-07
- Last Posted Date
- 2018-12-28
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 180
- Registration Number
- NCT02825108
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Evaluation of Autologous Adipose Derived Mesenchymal Stromal Cells (AD-MSC) Transplantation in Ultra Filtration Failure (UFF)
Phase 1
Completed
- Conditions
- Ultra Filtration Failure
- Interventions
- Biological: Intravenous injection
- First Posted Date
- 2016-06-16
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 10
- Registration Number
- NCT02801890
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Evaluation of Different Luteal Phase Support Methods in Patients With Poor Ovarian Response
Phase 3
- Conditions
- Infertility
- Interventions
- First Posted Date
- 2016-06-14
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 210
- Registration Number
- NCT02798653
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Utilization of Amniotic Membrane Extract Eye Drop (AMEED) on Human Corneal Healing
Phase 1
Completed
- Conditions
- Cornea Injury
- Interventions
- Biological: Amniotic Membrane Extract Eye Drop
- First Posted Date
- 2016-04-21
- Last Posted Date
- 2016-04-21
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 20
- Registration Number
- NCT02746848
Dual Ovarian Stimulation in the Same IVF/ICSI Cycles for Treatment of Poor Ovarian Responders
Phase 3
Completed
- Conditions
- Infertility
- Interventions
- Drug: Ovulation stimulation
- First Posted Date
- 2016-04-11
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 50
- Registration Number
- NCT02732808
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
The Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos
Phase 3
Completed
- Conditions
- Infertility
- Interventions
- Procedure: Blastocyte TransferringProcedure: Embryo Transferring
- First Posted Date
- 2016-02-12
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 220
- Registration Number
- NCT02681029
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)
Phase 1
Completed
- Conditions
- Limbal Stem Cell Deficiency (LSCD)
- Interventions
- Biological: Amniotic Membrane Extract Eye Drop (AMEED)
- First Posted Date
- 2016-01-07
- Last Posted Date
- 2016-01-07
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 10
- Registration Number
- NCT02649621
Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease
Phase 1
- Conditions
- Kienböck's Disease
- Interventions
- Biological: BM-MSC transplantation
- First Posted Date
- 2016-01-05
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 30
- Registration Number
- NCT02646007
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF)
Phase 1
- Conditions
- Premature Ovarian Failure
- Interventions
- Biological: Intraovarian injection of Adipose derived Stromal cells (ADSCs)
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Royan Institute
- Target Recruit Count
- 9
- Registration Number
- NCT02603744
- Locations
- 🇮🇷
Royan Institute, Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath